Transitioning to Pharma 4.0 offers new opportunities and challenges at the same time. This event provides the appropriate platform to discuss the best practices and experience of introducing, implementing and managing emerging technology capabilities. Main focus will be on analytics and data integrity, automation, the workforce of the future, technical and operational transformation, and end-to-end integration.
Thomas Halfmann, Global Head Production IT Life Sciences, will chair the first conference day and deliver the following presentation:
The Future of MES and IoT and Pharma 4.0
The concept of MES as a system to execute, monitor, track and report manufacturing operations in real time has been established in the pharmaceutical industry for more than 20 years. Today MES is a very critical component for most companies to embark onto the journey towards digitalization and Pharma 4.0. Although "MES for Pharma" was designed pre-IoT, it will remain as the core system to manage data and information for manufacturing of medicinal products and therefore is the key fundament for data integrity on the journey towards digitalization and Pharma 4.0. Key topics that will be discussed are:
- MES as being fundamental for safely releasing products to the market (and the patients)
- MES in cell & gene therapy manufacturing (needle-to-needle)
- Integrated information architecture of manufacturing and supply chain to ensure the safe release and supply of medicine to the market and patient
Read more about the Pharma 4.0 Smart Manufacturing Summit.